[searchandfilter fields="search,category" post_types="post"]
Sponsor:BiogenBrief Summary: The primary objective of the study is to evaluate the long-term safety and tolerability of BIIB067 in participants…
Sponsor:Annexon, Inc.Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of Intravenous ANX005…
Sponsor:Brainstorm-Cell TherapeuticsBrief Summary: This study will evaluate the safety and efficacy of repeated administration of NurOwn® (MSC-NTF cells) therapy, which…
Sponsor:University of MiamiBrief Summary: The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected…
Sponsor:OrphazymeBrief Summary: A multicenter, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of arimoclomol in amyotropic…
Sponsor:BiogenBrief Summary: The primary objective of this study is to evaluate the safety and tolerability of BIIB078 in adults with…
Sponsor:OrphazymeBrief Summary: A multicenter, non-randomized, open label trial, to assess long term safety and efficacy of Arimoclomol in subjects with…
Sponsor:BiogenBrief Summary: The primary objective of this study is to evaluate the safety, tolerability of single-ascending doses of BIIB100 in…
Sponsor:Powell Mansfield Inc.Brief Summary: This is a pilot study to examine the diagnostic utility of a novel transmembrane surface sensor,…
Sponsor:MediciNovaBrief Summary: A Phase 2b/3 multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy, safety and tolerability of…